ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - À¯Çüº°(Àΰ£ ÇÁ¸®¿Âº´, µ¿¹° ÇÁ¸®¿Âº´), ¾àÁ¦º°(Ç׿ì¿ïÁ¦, Ç×Á¤½Åº´Á¦), Áö¿ªº°, °æÀﺰ(2020-2030³â)
Prion Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity & Forecast Segmented By Type (Human Prion Diseases, Animal Prion Diseases), By Drug (Antidepressant, Antipsychotic Agents), By Region and Competition, 2020-2030F
»óǰÄÚµå : 1728373
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀåÀº 2024³â 49¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 4.49%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 64¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÁ¸®¿Â Áúȯ, Áï Àü¿°¼º ÇØ¸é»ó³úÁõ(TSEs)Àº ³ú¿¡ À߸ø Á¢Èù ÇÁ¸®¿Â ´Ü¹éÁúÀÌ ºñÁ¤»óÀûÀ¸·Î ÃàÀûµÇ¾î ¹ß»ýÇÏ´Â Èñ±ÍÇϰí Ä¡¸íÀûÀÎ ½Å°æ ÅðÇ༺ ÁúȯÀÔ´Ï´Ù. Å©·ÎÀÌÃ÷ÆçÆ® ¾ßÄߺ´(CJD), º¯Á¾ CJD(vCJD), Ä¡¸íÀûÀÎ °¡Á·¼º ºÒ¸éÁõ(FFI) µîÀÌ ÀÌ¿¡ ÇØ´çÇÕ´Ï´Ù. ½ÃÀå °³Ã´Àº Áúº´¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í, Áø´Ü¹ý °³¼±, È¿°úÀûÀÎ Ä¡·á¹ý °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß Ȱ¼ºÈ­ µî¿¡ ÈûÀÔ¾î ²ÙÁØÈ÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Ä¡·á¹ýÀº Á¸ÀçÇÏÁö ¾ÊÁö¸¸, ÇöÀç Ä¡·á Á¢±Ù¹ýÀº Áõ»ó °ü¸®¿Í ȯÀÚÀÇ »îÀÇ Áú¿¡ ÁßÁ¡À» µÐ ÁöÁöÀû Ä¡·á¹ýÀÔ´Ï´Ù. Àΰ£ ÇÁ¸®¿Âº´Àº ³ôÀº À¯º´·ü°ú ¿¬±¸ Ȱµ¿À¸·Î ÀÎÇØ ÁÖ¿ä ºÎ¹®ÀÌ µÇ¾ú½À´Ï´Ù. Ç׿ì¿ïÁ¦´Â ½Å°æÁõ»ó ¹× Á¤½ÅÁõ»óÀ» °ü¸®Çϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ÁÖ¿ä ¾àÁ¦±ºÀ¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. Áø´ÜÀÇ º¹À⼺, ³·Àº À¯º´·ü, Á¦ÇÑµÈ Ä¡·á ¿É¼Ç µîÀÇ °úÁ¦¿¡µµ ºÒ±¸Çϰí, ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸, ½Å°æ ÅðÇ༺ ¿¬±¸ ÀÚ±Ý Áö¿ø, ÷´Ü Ä¡·á¹ý ¸ð»ö¿¡ ´ëÇÑ Çõ½ÅÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 49¾ï 7,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 64¾ï 7,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 4.49%
±Þ¼ºÀå ºÎ¹® Àΰ£ ÇÁ¸®¿Âº´
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

ÇÁ¸®¿Âº´ À¯º´·ü Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

ÇÁ¸®¿Âº´¿¡ ´ëÇÑ Á¦ÇÑµÈ ÀÌÇØ

ÁÖ¿ä ½ÃÀå µ¿Çâ

»õ·Î¿î Ä¡·á Á¢±Ù¹ý

ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ Ä¡·á¹ýÀº ´ëºÎºÐ ½ÇÇè ´Ü°è¿¡ ÀÖÁö¸¸, ¹Ì·¡ÀÇ Áúº´ º¯Çü Ä¡·á¿¡ Èñ¸ÁÀ» ÁÖ°í ÀÖ¾î ÅõÀÚ¿Í ¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¦Ç° °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Prion Disease Treatment Market was valued at USD 4.97 Billion in 2024 and is projected to reach USD 6.47 Billion by 2030, growing at a CAGR of 4.49% during the forecast period. Prion diseases, or transmissible spongiform encephalopathies (TSEs), are rare, fatal neurodegenerative disorders resulting from the abnormal accumulation of misfolded prion proteins in the brain. These include conditions such as Creutzfeldt-Jakob Disease (CJD), variant CJD (vCJD), Fatal Familial Insomnia (FFI), and others. The market is witnessing steady expansion, supported by greater disease awareness, improved diagnostics, and increased research initiatives aimed at developing effective therapies. While no cure exists, current treatment approaches are largely supportive, focusing on symptom management and patient quality of life. Human prion diseases are the dominant segment, driven by higher prevalence and research activity. Antidepressants represent the leading drug class due to their role in managing neurological and psychiatric symptoms. Innovations in biomarker research, funding for neurodegenerative studies, and exploration of advanced therapeutic methods are expected to further propel market growth, despite challenges such as diagnostic complexity, low incidence rates, and limited treatment options.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.97 Billion
Market Size 2030USD 6.47 Billion
CAGR 2025-20304.49%
Fastest Growing SegmentHuman Prior Diseases
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Prion Diseases

The rising incidence of prion diseases globally is a major growth driver for the treatment market. These neurodegenerative disorders, though rare, are increasingly diagnosed due to advancements in medical technology and growing awareness among healthcare professionals. Enhanced diagnostic capabilities have made it possible to identify cases that were previously misdiagnosed or undetected, contributing to a perceived rise in prevalence. Additionally, the aging global population has amplified the incidence of diseases like sporadic CJD, which is more common in older adults. According to the National Library of Medicine, at least 485 cases of iatrogenic CJD (iCJD) have been documented worldwide, most of which occurred prior to 2012. These included cases linked to contaminated surgical tools, EEG needles, corneal transplants, and notably, human-derived growth hormones and dura mater grafts. As detection improves and awareness increases, the demand for prion disease treatments is expected to grow steadily.

Key Market Challenges

Limited Understanding of Prion Diseases

A major challenge hindering the development of effective prion disease therapies is the limited understanding of the diseases' underlying mechanisms. Prion disorders are complex, and their pathogenesis-particularly how prions replicate and cause neurodegeneration-remains only partially understood. This knowledge gap restricts the identification of viable drug targets and slows down therapeutic innovation. The intricacy of prion biology requires extensive research to unravel molecular pathways before advancing drug discovery. This lack of foundational understanding poses a significant barrier to the timely development and approval of effective treatments.

Key Market Trends

Emerging Therapeutic Approaches

Innovative treatment strategies are emerging as key trends in the prion disease treatment landscape. Researchers are investigating a range of novel approaches to halt or reverse disease progression.

These therapeutic innovations, though largely in experimental phases, offer hope for disease-modifying treatments in the future and are attracting increasing investment and research attention.

Key Market Players

Report Scope:

In this report, the Global Prion Disease Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Prion Disease Treatment Market, By Type:

Prion Disease Treatment Market, By Drug:

Prion Disease Treatment Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Prion Disease Treatment Market.

Available Customizations:

Global Prion Disease Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Prion Disease Treatment Market Outlook

6. North America Prion Disease Treatment Market Outlook

7. Europe Prion Disease Treatment Market Outlook

8. Asia-Pacific Prion Disease Treatment Market Outlook

9. South America Prion Disease Treatment Market Outlook

10. Middle East and Africa Prion Disease Treatment Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Prion Disease Treatment Market: SWOT Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â